Kim Ward
Impact in
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Intellectual Property and Patents 2
-
- Pharmaceutical Economics and Policy 3
- Co-authors
- Admire Dube (4 shared papers)David M. Sanders (3 shared papers)Allyson M Pollock (2 shared papers)Bruno Marchal (3 shared papers)Abhay B Kadam (1 shared paper)Mitchell G. Weiss (1 shared paper)Thubelihle Mathole (1 shared paper)Roger Jeffery (1 shared paper)
- Journals
- BMC Health Services Research (3 papers)Journal of Pharmaceutical Policy and Practice (2 papers)Health Policy and Planning (1 paper)Bulletin of the World Health Organization (1 paper)BMJ Open (1 paper)
- Partner nations
- South AfricaBelgiumUnited Kingdom
In The Last Decade
Kim Ward
17 papers receiving 376 citations
Peers
Comparison fields: 5 of 77
- Applied Microbiology and Biotechnology 18
- Toxicology 32
- Geriatrics and Gerontology 18
- Family Practice 7
- Economics and Econometrics 103
Countries citing papers authored by Kim Ward
This map shows the geographic impact of Kim Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Ward more than expected).
Fields of papers citing papers by Kim Ward
This network shows the impact of papers produced by Kim Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Ward. The network helps show where Kim Ward may publish in the future.
Co-authors
The 20 scholars most cited alongside Kim Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | 2015 | 45 | |
| 3 | 2018 | 33 | |
| 4 | 2015 | 33 | |
| 5 | 2014 | 30 | |
| 6 | 2014 | 28 | |
| 7 | 2017 | 23 | |
| 8 | 2003 | 18 | |
| 9 | 2017 | 18 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2016 | 10 | |
| 13 | 2024 | 8 | |
| 14 | 2017 | 6 | |
| 15 | 1989 | 5 | |
| 16 | Glutamic-oxaloacetic transaminase in semen of human, bull, and rabbit seminal plasma. | 1998 | 3 |
| 17 | 2024 | 3 |
About Kim Ward
Kim Ward is a scholar working on Management of Technology and Innovation, Economics and Econometrics, Public Health, Environmental and Occupational Health, Toxicology and Urology, having authored 17 papers that have together received 392 indexed citations. Recurring topics across this work include Pharmaceutical Quality and Counterfeiting (3 papers), Pharmaceutical Economics and Policy (3 papers), Intellectual Property and Patents (2 papers), Coronary Artery Anomalies (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Congenital Heart Disease Studies (1 paper), Global Maternal and Child Health (1 paper) and Mental Health Treatment and Access (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (18 citations), Toxicology (32 citations), Geriatrics and Gerontology (18 citations), Family Practice (7 citations) and Economics and Econometrics (103 citations). Kim Ward has collaborated with scholars based in South Africa, Belgium and United Kingdom. Frequent co-authors include Admire Dube, David M. Sanders, Allyson M Pollock, Bruno Marchal, Abhay B Kadam, Mitchell G. Weiss, Thubelihle Mathole, Roger Jeffery, Tamara Kredo and Henry Chukwuemeka Uro-Chukwu. Their work appears in journals such as BMC Health Services Research, Journal of Pharmaceutical Policy and Practice, Health Policy and Planning, Bulletin of the World Health Organization and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.